시장보고서
상품코드
1532822

동물용 항균 펩타이드 시장 : 유형별, 공급원별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2024-2032년)

Animal Antibacterial Peptide Market, By Type, By Source, By Application, By End-User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 369 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

동물용 항균 펩타이드 시장 규모는 2023년 34억 5,123만 달러로 2024-2032년 연평균 16.5% 성장할 것으로 예상됩니다.

동물용 항균 펩타이드 시장 - 시장 역학

특정 병원체를 표적으로 하는 신규 펩타이드에 대한 수요 증가로 동물용 항균 펩타이드 시장의 성장을 촉진

동물용 항균 펩타이드 시장은 동물 의료 분야에서 보다 정밀하고 효과적인 치료법으로의 전환을 반영하여 특정 병원균을 표적으로 하는 새로운 펩타이드에 대한 수요가 증가함에 따라 눈에 띄게 성장하고 있습니다. 예를 들어, 미국 농무부(USDA)의 연구에 따르면 대장균과 살모넬라균을 표적으로 하는 펩타이드가 가축의 감염률을 최대 50%까지 감소시키는 것으로 나타났습니다. 또한, Journal of Veterinary Science 저널에 게재된 연구에 따르면, 조정된 항균 펩타이드가 가금류의 호흡기 감염 발생률을 30% 가까이 감소시킬 수 있는 것으로 보고되었습니다. 이러한 추세는 Elanco와 Zoetis와 같은 유명 제약회사들이 펩타이드 기반 치료제 개발에 많은 자원을 투입하고 있으며, 이 부문의 R&D 자금은 지난 2년 동안 약 20% 증가했습니다.

동물용 항균 펩타이드 시장 - 주요 인사이트

당사의 리서치 애널리스트의 분석에 따르면, 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 16.5%의 CAGR로 매년 성장할 것으로 예상됩니다.

유형별로는 합성 펩타이드가 2023년 가장 큰 시장 점유율을 차지할 것으로 예측되었습니다.

공급원별로는 2023년 동물 유래가 주요 유형으로 나타났습니다.

용도별로는 2023년 동물용 의약품이 주요 유형이었습니다.

지역별로는 북미가 2023년 주요 수익원으로 꼽혔습니다.

동물용 항균 펩타이드 시장 - 세분화 분석:

동물용 항균 펩타이드 세계 시장은 유형, 공급원, 용도, 최종사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 합성 펩타이드와 천연 펩타이드의 두 가지 범주로 나뉩니다. 합성 펩타이드는 표적 적용과 확장성을 위해 설계되었으며, 천연 펩타이드는 동물에서 유래한 것으로 고유한 항균 특성과 생물학적 적합성을 설명합니다.

시장은 공급원에 따라 미생물 유래, 식물 유래, 동물 유래의 세 가지 범주로 나뉩니다. 세균 유래는 다양한 항균 펩타이드를 제공하고, 식물 유래는 항균 특성을 가진 생물 활성 화합물을 제공하며, 동물 유래는 천연 유래의 강력한 항균 효과를 가진 펩타이드를 제공합니다.

동물용 항균 펩타이드 시장 - 지리적 인사이트

미국과 캐나다로 대표되는 북미는 첨단 연구 시설과 혁신적인 수의학 솔루션에 대한 강한 관심으로 인해 주요 허브 역할을 하고 있으며, 미국 농무부와 많은 학술 기관이 펩타이드 연구에 적극적으로 기여하고 있습니다. 유럽, 특히 서유럽은 엄격한 규제 기준과 가축 관리에서 대체 치료법의 채택 증가로 인해 주목할 만한 지역으로 부상하고 있습니다. 아시아태평양에서는 중국과 인도와 같은 국가들이 대규모 농업 부문과 가축의 건강 증진에 중점을 두면서 주요 시장으로 부상하고 있습니다. 최근 보고서에 따르면 중국에서는 펩타이드 기반 동물용 의약품에 대한 투자가 지난 1년 동안 약 25% 급증했으며, 인도에서는 확대되는 축산 부문이 증가하는 질병 발생에 대처하기 위해 이러한 신기술을 빠르게 채택하고 있습니다.

동물용 항균 펩타이드 시장 - 경쟁 상황:

동물용 항균 펩타이드 시장의 경쟁 구도는 대형 제약사와 첨단 생명공학 기업의 활발한 융합으로 정의할 수 있습니다. 북미에서는 Zoetis, Elanco, Merck와 같은 선도 기업들이 광범위한 R&D 역량과 확고한 시장 입지를 활용하여 펩타이드 기반 치료법의 발전을 주도하고 있습니다. 이들 기업을 보완하는 것은 첨단 기술과 참신한 펩타이드 솔루션을 제공하는 신생 생명공학 기업들입니다. 최근 엘랑코와 펩티시스템즈(PeptiSystems)가 가축용 표적 항균 펩타이드를 공동 개발하기 위해 맺은 전략적 제휴는 이 시장에서 눈에 띄는 사례입니다. 이 제휴는 항생제 내성 감염의 증가라는 도전에 대응하기 위해 전문성을 결집하려는 업계의 움직임을 잘 보여줍니다.

목차

제1장 동물용 항균 펩타이드 시장 개요

  • 조사 범위
  • 시장 추정 연도

제2장 주요 요약

  • 시장 내역
  • 경쟁 인사이트

제3장 동물용 항균 펩타이드의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장 전망 동향

제4장 동물용 항균 펩타이드 산업 연구

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 매핑
  • 규제 프레임워크 분석

제5장 동물용 항균 펩타이드 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 동물용 항균 펩타이드 시장 상황

  • 동물용 항균 펩타이드 시장 점유율 분석, 2023년
  • 주요 제조업체별 내역 데이터
    • 기존 기업 분석
    • 신흥 기업 분석

제7장 동물용 항균 펩타이드 시장 - 유형별

  • 개요
    • 유형별 부문 점유율 분석
    • 합성 펩타이드
    • 천연 펩타이드

제8장 동물용 항균 펩타이드 시장 - 공급원별

  • 개요
    • 공급원별 부문 점유율 분석
    • 미생물 유래
    • 식물 유래
    • 동물 유래

제9장 동물용 항균 펩타이드 시장 - 용도별

  • 개요
    • 용도별 부문 점유율 분석
    • 동물 의료
    • 농업
    • 연구

제10장 동물용 항균 펩타이드 시장 - 최종사용자별

  • 개요
    • 최종사용자별 부문 점유율 분석
    • 동물 사료 제조업체
    • 수의 클리닉
    • 농업단체
    • 연구기관

제11장 동물용 항균 펩타이드 시장 - 지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제12장 주요 벤더 분석 - 동물용 항균 펩타이드 업계

  • 경쟁 대시보드
  • 기업 개요
    • Alltech
    • Animal Health International, Inc.
    • Bayer AG
    • Boehringer Ingelheim International GmbH
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Hill's Pet Nutrition, Inc.
    • Jurox Pty Ltd
    • Kemin Industries, Inc.
    • Merck Animal Health
    • Novartis Animal Health
    • Phibro Animal Health Corporation
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
    • 기타

제13장 애널리스트의 전방위 전망

ksm 24.09.03

REPORT HIGHLIGHT

Animal Antibacterial Peptide Market size was valued at USD 3,451.23 Million in 2023, expanding at a CAGR of 16.5% from 2024 to 2032.

The Animal Antibacterial Peptide (AAP) Market comprises peptides derived from animals that exhibit antimicrobial properties, crucial for developing new therapeutics and improving disease management in livestock and companion animals. The rising incidence of antibiotic-resistant infections in animals and the growing demand for alternative treatments are key factors propelling market growth. Conversely, high production costs and regulatory challenges associated with peptide-based products pose significant restraints. Opportunities abound in expanding applications in veterinary medicine and the development of novel peptides targeting specific pathogens. For instance, recent studies have highlighted that antimicrobial peptides can reduce infection rates in livestock by up to 40%, while investment in peptide research has increased by approximately 15% over the past year.

Animal Antibacterial Peptide Market- Market Dynamics

Rising Demand for Novel Peptides Targeting Specific Pathogens Fuels Growth in the Animal Antibacterial Peptide Market

The Animal Antibacterial Peptide Market is experiencing notable growth driven by the increasing demand for novel peptides that target specific pathogens, reflecting a shift towards more precise and effective treatments in veterinary medicine. For instance, research from the USDA has highlighted that peptides specifically targeting E. coli and Salmonella have shown up to a 50% reduction in infection rates among livestock. Furthermore, a study published in the Journal of Veterinary Science reported that tailored antimicrobial peptides could decrease the incidence of respiratory infections in poultry by nearly 30%. This trend is supported by investment from prominent pharmaceutical companies, such as Elanco and Zoetis, which are allocating significant resources to develop peptide-based therapies, with R&D funding in this area increasing by around 20% over the past two years.

Animal Antibacterial Peptide Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 16.5% over the forecast period (2024-2032)

Based on Type segmentation, Synthetic Peptides were predicted to show maximum market share in the year 2023

Based on Source segmentation, Animal Sources was the leading type in 2023

Based on Application segmentation, Veterinary Medicine was the leading type in 2023

Based on region, North America was the leading revenue generator in 2023

Animal Antibacterial Peptide Market- Segmentation Analysis:

The Global Animal Antibacterial Peptide Market is segmented based on Type, Source, Application, End-User, and Region.

The market is divided into two categories based on Type: Synthetic Peptides and Natural Peptides. Synthetic Peptides are engineered for targeted applications and scalability, while Natural Peptides, derived from animal sources, offer inherent antimicrobial properties and biological compatibility.

The market is divided into three categories based on Sources: Bacterial Sources, Plant Sources, and Animal Sources. Bacterial Sources provide diverse antimicrobial peptides, Plant Sources offer bioactive compounds with antimicrobial properties, and Animal Sources yield peptides with potent, naturally occurring antimicrobial effects.

Animal Antibacterial Peptide Market- Geographical Insights

North America, led by the United States and Canada, remains a major hub due to advanced research facilities and a strong focus on innovative veterinary solutions, with the USDA and numerous academic institutions actively contributing to peptide research. Europe, particularly Western Europe, is also a prominent region, driven by stringent regulatory standards and increasing adoption of alternative treatments in livestock management. In Asia-Pacific, countries like China and India are emerging as key markets due to their large agricultural sectors and growing emphasis on enhancing animal health. Recent reports indicate that China's investment in peptide-based veterinary products has surged by approximately 25% over the past year, while India's expanding livestock sector is rapidly adopting these new technologies to address rising disease outbreaks.

Animal Antibacterial Peptide Market- Competitive Landscape:

The Animal Antibacterial Peptide Market's competitive landscape is defined by a vibrant blend of major pharmaceutical companies and forward-thinking biotech firms. In North America, prominent players such as Zoetis, Elanco, and Merck are at the forefront, leveraging their extensive R&D capabilities and established market presence to drive advancements in peptide-based therapies. These companies are complemented by emerging biotech firms that bring cutting-edge technologies and novel peptide solutions to the table. A notable instance of strategic collaboration in this market is the recent partnership between Elanco and PeptiSystems, aimed at co-developing targeted antimicrobial peptides for livestock. This alliance highlights the industry's trend towards combining expertise to tackle the growing challenge of antibiotic-resistant infections.

Recent Developments:

In February 2020, CARB-X funds Lytica Therapeutics up to $16.9 million to develop antibacterial peptides against multidrug-resistant Gram-negative bacteria, targeting infections in the lungs and other parts of the body. The project aims to overcome the current limitations of antimicrobial peptides.

In July 2023, BioCote Limited and Eco Finish established a strategic partnership to integrate BioCote technology into antimicrobial surfaces for residential and commercial pools. This collaboration introduces additives designed to inhibit bacteria, algae, viruses, and other microbes, thereby improving safety and protection for swimmers.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Alltech

Animal Health International, Inc.

Bayer AG

Boehringer Ingelheim International GmbH

Ceva Sante Animale

Dechra Pharmaceuticals PLC

Elanco Animal Health Incorporated

Hill's Pet Nutrition, Inc.

Jurox Pty Ltd

Kemin Industries, Inc.

Merck Animal Health

Novartis Animal Health

Phibro Animal Health Corporation

Vetoquinol S.A.

Virbac

Zoetis Inc.

Others

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Synthetic Peptides
  • Natural Peptides

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY SOURCE- MARKET ANALYSIS, 2019 - 2032

  • Bacterial Sources
  • Plant Sources
  • Animal Sources

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Veterinary Medicine
  • Agriculture
  • Research

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

  • Animal Feed Manufacturers
  • Veterinary Clinics
  • Agricultural Organizations
  • Research Institutions

GLOBAL ANIMAL ANTIBACTERIAL PEPTIDE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Animal Antibacterial Peptide Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Animal Antibacterial Peptide Market Snippet by Type
    • 2.1.2. Animal Antibacterial Peptide Market Snippet by Source
    • 2.1.3. Animal Antibacterial Peptide Market Snippet by Application
    • 2.1.4. Animal Antibacterial Peptide Market Snippet by End-User
    • 2.1.5. Animal Antibacterial Peptide Market Snippet by Country
    • 2.1.6. Animal Antibacterial Peptide Market Snippet by Region
  • 2.2. Competitive Insights

3. Animal Antibacterial Peptide Key Market Trends

  • 3.1. Animal Antibacterial Peptide Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Animal Antibacterial Peptide Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Animal Antibacterial Peptide Market Opportunities
  • 3.4. Animal Antibacterial Peptide Market Future Trends

4. Animal Antibacterial Peptide Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Animal Antibacterial Peptide Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Animal Antibacterial Peptide Market Landscape

  • 6.1. Animal Antibacterial Peptide Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Animal Antibacterial Peptide Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2. Synthetic Peptides
    • 7.1.3. Natural Peptides

8. Animal Antibacterial Peptide Market - By Source

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Source, 2023 & 2032 (%)
    • 8.1.2. Bacterial Sources
    • 8.1.3. Plant Sources
    • 8.1.4. Animal Sources

9. Animal Antibacterial Peptide Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 9.1.2. Veterinary Medicine
    • 9.1.3. Agriculture
    • 9.1.4. Research

10. Animal Antibacterial Peptide Market - By End-User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-User, 2023 & 2032 (%)
    • 10.1.2. Animal Feed Manufacturers
    • 10.1.3. Veterinary Clinics
    • 10.1.4. Agricultural Organizations
    • 10.1.5. Research Institutions

11. Animal Antibacterial Peptide Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Animal Antibacterial Peptide Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Animal Antibacterial Peptide Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Animal Antibacterial Peptide Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Animal Antibacterial Peptide Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Animal Antibacterial Peptide Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Source, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Animal Antibacterial Peptide Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Alltech
    • 12.2.2. Animal Health International, Inc.
    • 12.2.3. Bayer AG
    • 12.2.4. Boehringer Ingelheim International GmbH
    • 12.2.5. Ceva Sante Animale
    • 12.2.6. Dechra Pharmaceuticals PLC
    • 12.2.7. Elanco Animal Health Incorporated
    • 12.2.8. Hill's Pet Nutrition, Inc.
    • 12.2.9. Jurox Pty Ltd
    • 12.2.10. Kemin Industries, Inc.
    • 12.2.11. Merck Animal Health
    • 12.2.12. Novartis Animal Health
    • 12.2.13. Phibro Animal Health Corporation
    • 12.2.14. Vetoquinol S.A.
    • 12.2.15. Virbac
    • 12.2.16. Zoetis Inc.
    • 12.2.17. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제